Regulating tissue engineering
Tissue engineering is a radical new approach to the repair and replacement of damaged or diseased body tissues. Cells, often seeded into or shaped around a biomaterial matrix, are used to replace damaged or diseased tissue or stimulate repair by the body. Because it is an area of tremendous focus an...
Saved in:
| Published in | Materials today (Kidlington, England) Vol. 7; no. 5; pp. 48 - 55 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier Ltd
01.05.2004
|
| Online Access | Get full text |
Cover
Loading…
| Summary: | Tissue engineering is a radical new approach to the repair and replacement of damaged or diseased body tissues. Cells, often seeded into or shaped around a biomaterial matrix, are used to replace damaged or diseased tissue or stimulate repair by the body. Because it is an area of tremendous focus and achievement, there is a risk that technical developments will outstrip the capacity of existing regulatory frameworks to cope with these novel products. Australia, the USA, and Canada are somewhat ahead of Japan in establishing a feasible regulatory approach. All four are currently ahead of the European Union (EU), but individual European countries and the EU as a whole are catching up. However, for the foreseeable future, it may still be possible in certain European countries to use autologous cell therapies in hospitals and market allogeneic tissue-engineered products, especially skin replacements, without regulatory control. |
|---|---|
| ISSN: | 1369-7021 1873-4103 |
| DOI: | 10.1016/S1369-7021(04)00235-4 |